Replikins Oral Vaccine Synthesized in 7 days protects 91% of Shrimp Against Lethal Virus
Replikins, Ltd. has announced development of a chemically synthesized vaccine specific to a Taura Syndrome virus structure based on its patented Replikins™ technology. When the vaccine was administered orally to shrimp, 91% survived a challenge by the lethal Taura virus. The effectiveness of this vaccine, and its rapid production cycle (7 days), represent an important proof of concept for developing vaccines against a range of rapidly replicating high lethality virus outbreaks. Boston, MA (PRWEB) March 11, 2008 -- Replikins, Ltd. has announced development of a chemically synthesized vaccine specific to a Taura Syndrome virus structure based on its patented Replikins™ technology. When the vaccine was administered orally to shrimp, 91% survived a challenge by the lethal Taura virus. The specificity of the protective effect was established in control groups by chemically blocking the active regions in the vaccine, and as a result the protective effect was lost in these control groups. The effectiveness of this vaccine, and its rapid production cycle (7 days), represent an important proof of concept for developing vaccines against a range of rapidly replicating high lethality virus outbreaks. For counteracting emerging infectious disease, early detection and rapid response are critical. Replikin contributions to date are both in early detection and rapid response: 1) Advance warning previously was not possible until it was found in H5N1 influenza that an increase in the virus replikin concentration signalled one year in advance that the outbreak was coming, and indicated the country in which this would occur (FluForecast™, Indonesia). 2) The production of vaccines by other methods has required 3 to 12 months, by which time the epidemic may have come and gone, or the vaccine effectiveness reduced or lost because the target changed due to mutation. In contrast, the replikins vaccine found effective here was manufactured synthetically in 7 days. Viruses lethal to shrimp have been responsible for large losses to aquaculture worldwide. Replikins is forming a division to focus on these viruses. The company is also pursuing development of synthetic vaccine products based on replikin epitopes, Syntopes™, for the control of fish hemorrhagic viruses and other lethal aquatic microorganisms. ###
Simillar Articles
 | | High Host Mortality Rate Quantitatively Related to High Virus Replikin Count |
| In a presentation at the World Aquaculture Conference in San
Antonio, Texas, Replikins Ltd. reported that the concentration
of replikin genome elements in five different viruses - human H5N1... |
|
| | Increases in West Nile Virus Replikin Concentrations Precede Increases in the Number of Human Cases |
| Replikins, Ltd. has found that the replikin concentration of West Nile Virus increased annually through two distinct cycles as the virus expanded in the U.S.: the first from 2000 to 2003, and the... |
|
| | A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as... |
| WHO and CDC have stated that the predictive accuracy of their annual formulations for human influenza vaccines is "suboptimal" - often correct less than 50% of the time, especially for seniors.... |
|
| | H5N1 Virus Replikin Gene Counts Indicate a New More Virulent Influenza Cycle Has Begun |
| Replikins Ltd. has found that H5N1 virus replikin peak gene counts in 2007 in Hong Kong, Russia, Indonesia, Vietnam and Israel indicate that a new replikin cycle has begun. The mean replikin count... |
|
| | FluForecast Trial in 2006 Predicted High Human H5N1 Mortality in Indonesia |
| When H5N1 was thought to be quiescent in 2006, in a prospective open trial, FluForecast®, a software program which measures virus gene proteins, predicted high human mortality H5N1 outbreaks to... |
|
|
